Flavii Therapeutics and Danae Urogenomics, winners of Élan Vital 2026
Flavii Therapeutics and Danae Urogenomics have been selected as the winning projects in the first edition of the Élan Vital Programme, organised by the HiTT Foundation. The programme is designed to accelerate early-stage business projects in the fields of health and life sciences. The winning companies will each receive an investment valued at 20,000 euros.
-> Continue reading Flavii Therapeutics and Danae Urogenomics, winners of Élan Vital 2026